CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... [Yahoo! Finance]
Cytosorbents Corporation (CTSO)
Last cytosorbents corporation earnings: 11/5 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cytosorbents.com
Company Research
Source: Yahoo! Finance
Direct International Sales (excluding Germany): Increased 13% to $8.6 million. Distributor Sales: Increased 11.4% to $16.5 million. Germany Sales: Decreased 10% to $11.8 million. Gross Margin: 71% for the full year, 74% in Q4. Total Operating Expenses: $41.2 million, relatively flat year-over-year. Operating Loss: Improved by 10% to $14.7 million. Adjusted Net Loss: $14.2 million or $0.23 per share. Adjusted EBITDA Loss: Improved by 9% to $10.5 million. Q4 Revenue: $9.2 million, up 1% year-over-year. Q4 Operating Loss: $4.6 million. Q4 Net Loss: $5.5 million or $0.09 per share. Total Cash, Cash Equivalents, and Restricted Cash: $7.8 million as of December 31. Warning! GuruFocus has detected 4 Warning Signs with CTSO. Is CTSO fairly valued? Test your thesis with our free DCF calculator. Release Date: March 25, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points CytoSorbents Corp ( NA
Show less
Read more
Impact Snapshot
Event Time:
CTSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTSO alerts
High impacting Cytosorbents Corporation news events
Weekly update
A roundup of the hottest topics
CTSO
News
- Cytosorbents (CTSO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.MarketBeat
- Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth [Seeking Alpha]Seeking Alpha
- CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business HighlightsPR Newswire
- CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026PR Newswire
CTSO
Earnings
- 3/25/26 - Miss
CTSO
Sec Filings
- 3/25/26 - Form 8-K
- 2/13/26 - Form SCHEDULE
- CTSO's page on the SEC website